Faeth Therapeutics's total assets for Q2 2026 were $189.31M, a decrease of -7.83% from the previous quarter. DE:4070 total liabilities were $16.35M for the fiscal quarter, a 15.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.